Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

作者：黄莺美国Moderna公司的专利官司持续不断。一周前，2024年10月12日，葛兰素史克公司（GSK）向美国特拉华州地方法院起诉Moderna，指控其COVID-19疫苗Spikevax以及今年5月份获得FDA批准的RNA呼吸道合胞病毒(RSV ...

We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

作者：黄莺俗话说人红是非多。在新冠疫情期间，凭借mRNA疫苗大获成功的Moderna公司，从年营收只有几千万美元的公司，一举跨入年营收200亿美元的公司行列。而这为其也带来了越来越多的专利纠纷。2021年，Moderna与美国国立卫生研究院的mRNA ...

Moderna ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

周三，美国西北大学 (Northwestern University)在特拉华州联邦法院对Moderna (MRNA.US)提起了一项新的专利诉讼，指控该公司滥用该校的创新成果来开发其重磅的新冠疫苗Spikevax。

Moderna Inc.’s shots for Covid-19 and respiratory syncytial virus infringe as many as seven GSK Plc patents related to mRNA ...

Eoneren/E+ via Getty Images Short interest for healthcare stocks in S&P 500 increased during September end vs.

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...